Contineum Therapeutics, Inc. (CTNM) Form 10-Q Quarterly Reports
Contineum Therapeutics, Inc. (CTNM) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: CTNM
CIK: 1855175
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2023 12:00:00 AM
Lead Engagement PartnerRyan Rowland
Audit LocationSan Diego, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 144 | 2026-10-01 | — | 144 Filing | 0001950047-26-009932 | View SEC Doc Filr Page |
| 8-K | 2026-09-14 | 2026-09-14 | 8-K | 0001628280-26-061834 | View SEC Doc Filr Page |
| 4 | 2026-09-08 | 2026-09-08 | FORM 4 | 0001628280-26-060962 | View SEC Doc Filr Page |
| 144 | 2026-09-08 | — | 144 Filing | 0001950047-26-009206 | View SEC Doc Filr Page |
| 144 | 2026-09-01 | — | 144 Filing | 0001950047-26-008923 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001172661-26-003422 | View SEC Doc Filr Page |
| 4 | 2026-08-03 | 2026-08-03 | FORM 4 | 0001628280-26-052031 | View SEC Doc Filr Page |
| 144 | 2026-08-03 | — | 144 Filing | 0001950047-26-007517 | View SEC Doc Filr Page |
| 144 | 2026-08-03 | — | 144 Filing | 0001950047-26-007509 | View SEC Doc Filr Page |
| 10-Q | 2026-07-30 | 2026-06-30 | 10-Q | 0001628280-26-051054 | View SEC Doc Filr Page |
| 8-K | 2026-07-30 | 2026-07-30 | 8-K | 0001628280-26-051051 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-27 | — | SCHEDULE 13G Filing | 0002012383-26-002243 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-17 | — | SCHEDULE 13G/A Filing | 0001104659-26-084693 | View SEC Doc Filr Page |
| 8-K | 2026-07-13 | 2026-07-13 | 8-K | 0001628280-26-048023 | View SEC Doc Filr Page |
| 4 | 2026-07-10 | 2026-07-08 | FORM 4 | 0001628280-26-047909 | View SEC Doc Filr Page |
| 4 | 2026-07-08 | 2026-07-08 | FORM 4 | 0001628280-26-047710 | View SEC Doc Filr Page |
| 144 | 2026-07-08 | — | 144 Filing | 0001950047-26-006968 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-06-30 | FORM 4 | 0001628280-26-047058 | View SEC Doc Filr Page |
| 4 | 2026-07-01 | 2026-06-30 | FORM 4 | 0001628280-26-046654 | View SEC Doc Filr Page |
| 4 | 2026-07-01 | 2026-06-30 | FORM 4 | 0001628280-26-046653 | View SEC Doc Filr Page |
| 144 | 2026-07-01 | — | 144 Filing | 0001950047-26-006723 | View SEC Doc Filr Page |
| 144 | 2026-06-30 | — | 144 Filing | 0001950047-26-006667 | View SEC Doc Filr Page |
| 144 | 2026-06-30 | — | 144 Filing | 0001950047-26-006666 | View SEC Doc Filr Page |
| 144 | 2026-06-30 | — | 144 Filing | 0001950047-26-006664 | View SEC Doc Filr Page |
| 4 | 2026-06-26 | 2026-06-26 | FORM 4 | 0001628280-26-045845 | View SEC Doc Filr Page |